Why don't patients take their medicine? Reasons and solutions in psychiatry †

Over the course of a year, about three-quarters of patients prescribed psychotropic medication will discontinue, often coming to the decision themselves and without informing a health professional. Costs associated with unplanned discontinuation may be substantial if left uncorrected. Partial non-adherence (much more common than full discontinuation) can also be detrimental, although some patients rationally adjust their medication regimen without ill-effect. This article reviews the literature on non-adherence, whether intentional or not, and discusses patients’ reasons for failure to concord with medical advice, and predictors of and solutions to the problem of non-adherence.

[1]  Jennifer. Hall A question of choice. , 2009, The practising midwife.

[2]  A. Mitchell,et al.  Why don’t patients attend their appointments? Maintaining engagement with psychiatric services , 2007 .

[3]  A. Mitchell Reluctance to disclose difficult diagnoses: a narrative review comparing communication by psychiatrists and oncologists , 2007, Supportive Care in Cancer.

[4]  R. Epstein,et al.  Types of information physicians provide when prescribing antidepressants , 2006, Journal of General Internal Medicine.

[5]  A. Mitchell Adherence behaviour with psychotropic medication is a form of self-medication. , 2007, Medical hypotheses.

[6]  A. Mitchell Depressed patients and treatment adherence , 2006, The Lancet.

[7]  A. Mitchell High medication discontinuation rates in psychiatry: how often is it understandable? , 2006, Journal of clinical psychopharmacology.

[8]  Alexander L. Miller,et al.  Defining and assessing adherence to oral antipsychotics: a review of the literature. , 2005, Schizophrenia bulletin.

[9]  S. Kang,et al.  P.3.081 Antipsychotic compliance and maintenance dosage in admitted patients with schizophrenia who had been followed up over 6 months , 2005, European Neuropsychopharmacology.

[10]  A. Lippman Adherence to medication. , 2005, The New England journal of medicine.

[11]  J. Calabrese,et al.  Relationship of Mania Symptomatology to Maintenance Treatment Response with Divalproex, Lithium, or Placebo , 2005, Neuropsychopharmacology.

[12]  R. Gray,et al.  A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. , 2005, Journal of advanced nursing.

[13]  J. Lieberman,et al.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.

[14]  Alexander L. Miller,et al.  Drug Adherence: Effects of Decreased Visit Frequency on Adherence to Clozapine Therapy , 2005, Pharmacotherapy.

[15]  Eve A Kerr,et al.  The role of patient-physician trust in moderating medication nonadherence due to cost pressures. , 2005, Archives of internal medicine.

[16]  C. Ko,et al.  Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: Prospective study , 2005, Psychiatry and clinical neurosciences.

[17]  E. Friedman,et al.  Patients' understanding of their treatment plans and diagnosis at discharge. , 2005, Mayo Clinic proceedings.

[18]  P. Areán,et al.  Adherence to antidepressant medications in black and Latino elderly patients. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[19]  Hayden B Bosworth,et al.  Intentional and Unintentional Nonadherence to Antihypertensive Medication , 2005, The Annals of pharmacotherapy.

[20]  Amar K. Das,et al.  Depression in US Hispanics: diagnostic and management considerations in family practice. , 2005, The Journal of the American Board of Family Practice.

[21]  H. Jackson,et al.  Role of Stigma and Attitudes Toward Help-Seeking from a General Practitioner for Mental Health Problems in a Rural Town , 2005, The Australian and New Zealand journal of psychiatry.

[22]  S. Marcus,et al.  Treatment compliance in patients with comorbid psychiatric and substance use disorders. , 2005, The American journal on addictions.

[23]  C. Mullins,et al.  Persistence, Switching, and Discontinuation Rates Among Patients Receiving Sertraline, Paroxetine, and Citalopram , 2005, Pharmacotherapy.

[24]  M. Olfson,et al.  Male sexual dysfunction and quality of life in schizophrenia. , 2005, The Journal of clinical psychiatry.

[25]  Jodi M. Gonzalez,et al.  Adherence to mental health treatment in a primary care clinic. , 2005, The Journal of the American Board of Family Practice.

[26]  M. Eaddy,et al.  Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population. , 2005, Clinical therapeutics.

[27]  D. Nease,et al.  Adherence to Maintenance-Phase Antidepressant Medication as a Function of Patient Beliefs About Medication , 2005, The Annals of Family Medicine.

[28]  M. Lambert,et al.  Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence , 2004, European Psychiatry.

[29]  S. Francis,et al.  Building concordant relationships with patients starting antidepressant medication. , 2004, Patient education and counseling.

[30]  W. Lowenstein,et al.  [Risk factors of early drop-out during induction of high-dose buprenorphine substitution therapy. A study of 1085 opiate addicts]. , 2004, Presse medicale.

[31]  K. Cox,et al.  A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance , 2004, Health expectations : an international journal of public participation in health care and health policy.

[32]  P. Weiden,et al.  Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. , 2004, Psychiatric services.

[33]  M. Ritsner,et al.  Subjective Response to Antipsychotics of Schizophrenia Patients Treated in Routine Clinical Practice: A Naturalistic Comparative Study , 2004, Journal of clinical psychopharmacology.

[34]  H. Tobi,et al.  Refill rate of antipsychotic drugs: an easy and inexpensive method to monitor patients' compliance by using computerised pharmacy data , 2004, Pharmacoepidemiology and drug safety.

[35]  R Horne,et al.  Patients’ problems with new medication for chronic conditions , 2004, Quality and Safety in Health Care.

[36]  B. Turetsky,et al.  Patient Attitudes towards Surgically Implantable, Long-Term Delivery of Psychiatric Medicine , 2004, Neuropsychopharmacology.

[37]  Christian R. Dolder,et al.  Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. , 2004, The American journal of psychiatry.

[38]  T. Pachinger,et al.  Medication adherence among psychotic patients before admission to inpatient treatment. , 2004, Psychiatric services.

[39]  T. Strandberg,et al.  Detection and documentation of dementia and delirium in acute geriatric wards. , 2004, General hospital psychiatry.

[40]  M. Tansella,et al.  How often do patients with psychosis fail to adhere to treatment programmes? A systematic review , 2003, Psychological Medicine.

[41]  S. Roose Compliance: the impact of adverse events and tolerability on the physician’s treatment decisions , 2003, European Neuropsychopharmacology.

[42]  C. Sannibale,et al.  Aftercare attendance and post-treatment functioning of severely substance dependent residential treatment clients. , 2003, Drug and alcohol review.

[43]  M. Angermeyer,et al.  Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. , 2003, Pharmacopsychiatry.

[44]  David W Bates,et al.  Use of chart and record reviews to detect medication errors in a state psychiatric hospital. , 2003, Psychiatric services.

[45]  Thomas Pollmächer,et al.  Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. , 2003, Journal of psychiatric research.

[46]  B. Sleath,et al.  Hispanic ethnicity, physician-patient communication, and antidepressant adherence. , 2003, Comprehensive psychiatry.

[47]  K. Rosenberg,et al.  A Survey of Sexual Side Effects Among Severely Mentally Ill Patients Taking Psychotropic Medications: Impact on Compliance , 2003, Journal of sex & marital therapy.

[48]  Richard Lewis A question of choice. , 1992, The Health service journal.

[49]  Diana O Perkins,et al.  Predictors of noncompliance in patients with schizophrenia. , 2002, The Journal of clinical psychiatry.

[50]  Jan Scott,et al.  Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. , 2002, The American journal of psychiatry.

[51]  J. Lieberman,et al.  Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder , 2002, Schizophrenia Research.

[52]  L. Markson,et al.  Discontinuation of use and switching of antidepressants: influence of patient-physician communication. , 2002, JAMA.

[53]  Laurel,et al.  Pharmacy Data Identify Poorly Adherent Patients With Schizophrenia at Increased Risk for Admission , 2002, Medical care.

[54]  Gill Livingston,et al.  ‘Just keep taking the tablets’: adherence to antidepressant treatment in older people in primary care , 2002, International journal of geriatric psychiatry.

[55]  Shubulade Smith,et al.  Sexual dysfunction in patients taking conventional antipsychotic medication , 2002, British Journal of Psychiatry.

[56]  A. Mitchell,et al.  The quality of psychotropic drug prescribing in patients in psychiatric units for the elderly , 2002, Aging & mental health.

[57]  S. Hurt,et al.  Discontinuing or Switching Selective Serotonin-Reuptake Inhibitors , 2002, The Annals of pharmacotherapy.

[58]  B. Svarstad,et al.  Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. , 2002, Journal of the American Pharmaceutical Association.

[59]  T. Fahy,et al.  Is there a role for the depot clinic in the modern management of schizophrenia , 2001 .

[60]  J. Cramer,et al.  A systematic review of the associations between dose regimens and medication compliance. , 2001, Clinical therapeutics.

[61]  B. Svarstad,et al.  Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. , 2001, Psychiatric services.

[62]  D. Sharp,et al.  Precursors of compliance with lithium treatment in affective disorders , 2001 .

[63]  W. Fakhoury,et al.  Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline , 2001, International clinical psychopharmacology.

[64]  K. Brown,et al.  Informed consent to medication in long-term psychiatric in-patients , 2001 .

[65]  M. Angermeyer,et al.  Patients' and relatives' assessment of clozapine treatment , 2001, Psychological Medicine.

[66]  G. Alexopoulos,et al.  Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. , 2001, The American journal of psychiatry.

[67]  K. Demyttenaere,et al.  Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events. , 2001, The Journal of clinical psychiatry.

[68]  K A McKibbon,et al.  Interventions for helping patients to follow prescriptions for medications. , 2002, The Cochrane database of systematic reviews.

[69]  P. Weiden,et al.  Obesity as a risk factor for antipsychotic noncompliance , 2000, European Neuropsychopharmacology.

[70]  E. Vieta,et al.  Clinical factors associated with treatment noncompliance in euthymic bipolar patients. , 2000, The Journal of clinical psychiatry.

[71]  B. Svarstad,et al.  Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. , 2000, Patient education and counseling.

[72]  Jan Scott,et al.  Predicting medication adherence in severe mental disorders , 2000, Acta psychiatrica Scandinavica.

[73]  C Rayner,et al.  Informed consent. , 2000, British journal of plastic surgery.

[74]  F. Baylé,et al.  [Survey on the announcement of schizophrenia diagnosis in France]. , 1999, L'Encephale.

[75]  T. Hökfelt,et al.  Neuropeptide signalling in the CNS: Increasing evidence for a role in psychiatric and neurodegenerative diseases , 1999, European Neuropsychopharmacology.

[76]  W. Fakhouri Extent of distress caused by adverse experiences associated with antipsychotic treatment , 1999, European Neuropsychopharmacology.

[77]  N. Kleindienst,et al.  Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. , 1999, International clinical psychopharmacology.

[78]  S. Connolly,et al.  Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. , 1999, Psychosomatic medicine.

[79]  R G Priest,et al.  Changes in public attitudes to depression during the Defeat Depression Campaign , 1998, British Journal of Psychiatry.

[80]  S. Meryn Improving doctor-patient communication , 1998, BMJ.

[81]  R. Rosenheck,et al.  Compliance with medication regimens for mental and physical disorders. , 1998, Psychiatric services.

[82]  K. Demyttenaere Noncompliance with antidepressants: who's to blame? , 1998, International clinical psychopharmacology.

[83]  R. Rosenheck,et al.  A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. , 1997, The New England journal of medicine.

[84]  S. Hoge,et al.  Prospective study of patients' refusal of antipsychotic medication under a physician discretion review procedure. , 1997, The American journal of psychiatry.

[85]  W S Fenton,et al.  Determinants of medication compliance in schizophrenia: empirical and clinical findings. , 1997, Schizophrenia bulletin.

[86]  B. Mcfarland,et al.  Lithium use and discontinuation in a health maintenance organization. , 1996, The American journal of psychiatry.

[87]  Barbara Gandek,et al.  Characteristics of Physicians with Participatory Decision-Making Styles , 1996, Annals of Internal Medicine.

[88]  G. Makoul,et al.  Health promotion in primary care: physician-patient communication and decision making about prescription medications. , 1995, Social science & medicine.

[89]  H. Morgenstern,et al.  Identifying modifiable risk factors for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi. , 1995, The American journal of psychiatry.

[90]  C. Thompson,et al.  The compliance with antidepressants in general practice , 1994, Journal of psychopharmacology.

[91]  Carol Lynn Thompson,et al.  Doctor-Patient Communication: Is Patient Knowledge of Medical Terminology Improving? , 1993 .

[92]  N. Col,et al.  The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. , 1990, Archives of internal medicine.

[93]  D. Tantam,et al.  Clinical characteristics, health beliefs and compliance with maintenance treatment: a comparison between regular and irregular attenders at a depot clinic , 1989, Acta psychiatrica Scandinavica.

[94]  J. Mamon,et al.  Utility of the health belief model in examining medication compliance among psychiatric outpatients. , 1987, Social science & medicine.

[95]  D. A. Johnson Depression: Treatment compliance in general practice , 1981, Acta psychiatrica Scandinavica. Supplementum.

[96]  T. Putten,et al.  Drug refusal in schizophrenia and the wish to be crazy. , 1976, Archives of general psychiatry.

[97]  C. Joyce,et al.  QUANTITATIVE STUDY OP DOCTOR-PATIENT COMMUNICATION , 1969 .

[98]  C. Joyce,et al.  Quantitative study of doctor-patient communication. , 1969, The Quarterly journal of medicine.